Original Research
Published on 07 Nov 2024
In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486856
- 3,080 views
- 3 citations
